News
Ascletis Pharma begins patient dosing in US phase I study of ASC50, an oral small molecule IL-17 inhibitor for psoriasis treatment: Hong Kong Thursday, June 19, 2025, 14:00 Hrs [I ...
Macquarie University’s new study shows DNA 'glue' could help prevent and treat age related disorders: Our Bureau, Bengaluru Thursday, June 19, 2025, 17:15 Hrs [IST] Macquarie Un ...
Nikon Instruments and Astellas collaborate to offer SakuLab-Cambridge resident companies access to advanced imaging capabilities: Melville, New York Thursday, June 19, 2025, 17:00 ...
Our Bureau, Bengaluru Thursday, June 19, 2025, 15:35 Hrs [IST] ...
Camurus announces positive results from POSITANO phase 2b study of octreotide SC depot in patients with symptomatic polycystic liver disease: Lund, Sweden Thursday, June 19, 2025, ...
Our Bureau, Mumbai Thursday, June 19, 2025, 16:15 Hrs [IST] ...
Waters unveils Alliance iS HPLC System Software, setting standards for end-to-end traceability and data integrity: Our Bureau, Bengaluru Thursday, June 19, 2025, 14:15 Hrs [IST] W ...
Ratio Therapeutics & Nusano ink long-term, multi-isotope supply agreement to boost production of cancer radiopharmaceuticals: Boston Thursday, June 19, 2025, 13:00 Hrs [IST] Ratio ...
ChoiceSpine launches ChoiceSpine App for surgical use with eCential robotics Op.n platform: Knoxville Thursday, June 19, 2025, 16:00 Hrs [IST] ChoiceSpine LLC, a privately-held US ...
Singlera Genomics, partners report results from GUIDE prospective cohort study: San Diego Thursday, June 19, 2025, 18:00 Hrs [IST] Singlera Genomics, a biotechnology company focus ...
BioIVT introduces Visionaire to enhance drug development workflows, drive actionable insights for precision medicine: Westbury, New York Thursday, June 19, 2025, 15:00 Hrs [IST] B ...
Suraksha Diagnostics, a leading diagnostics service provider in Eastern India has announced its collaboration with United Imaging, a global leader in advanced imaging technologies, with an aim to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results